Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NeoGenomics, Inc. - Common Stock (NQ:NEO)

9.540 +0.040 (+0.42%)
Streaming Delayed Price Updated: 4:00 PM EST, Mar 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,819,383
Open 9.220
Bid (Size) 9.240 (200)
Ask (Size) 9.850 (200)
Prev. Close 9.500
Today's Range 9.035 - 9.775
52wk Range 4.720 - 13.74
Shares Outstanding 122,816,314
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
3 Reasons to Avoid NEO and 1 Stock to Buy Instead
What a fantastic six months it’s been for NeoGenomics. Shares of the company have skyrocketed 48.3%, hitting $9.94. This was partly thanks to its solid quarterly results, and the performance may have... 
Via StockStory
News headline image
NeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types
From NeoGenomics, Inc.
Via Business Wire

Performance

YTD
-18.9%
-18.9%
1 Month
-22.5%
-22.5%
3 Month
-21.0%
-21.0%
6 Month
+8.3%
+8.3%
1 Year
-0.4%
-0.4%

More News

Read More
News headline image
5 Insightful Analyst Questions From NeoGenomics’s Q4 Earnings Call
Via StockStory
Topics Earnings
NeoGenomics Inc (NASDAQ:NEO) Beats Q4 Earnings Estimates and Provides 2026 Guidance ↗
Via Chartmill
News headline image
Why NeoGenomics (NEO) Shares Are Falling Today
Via StockStory
Topics Artificial Intelligence
News headline image
NeoGenomics to Participate in Upcoming Investor Conferences
From NeoGenomics, Inc.
Via Business Wire
News headline image
NEO Q4 Deep Dive: Product Mix Shift and Guidance Weigh on Outlook
Via StockStory
News headline image
NeoGenomics (NEO) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
NeoGenomics’s (NASDAQ:NEO) Q4 CY2025 Sales Beat Estimates
Via StockStory
Topics Earnings
News headline image
NeoGenomics Reports Fourth Quarter and Full Year 2025 Results
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics (NEO) Q4 Earnings Report Preview: What To Look For
Via StockStory
Topics Artificial Intelligence World Trade
News headline image
NeoGenomics Introduces PanTracer Pro to Support Timely, Informed Solid Tumor Therapy Selection
From NeoGenomics, Inc.
Via Business Wire
News headline image
1 Stock Under $50 Worth Your Attention and 2 We Brush Off
Via StockStory
News headline image
NeoGenomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
3 Cash-Burning Stocks with Warning Signs
Via StockStory
Topics Electric Vehicles
News headline image
NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics Appoints Diagnostics and Lab Services Industry Veteran John P. “Jack” Kenny to its Board of Directors
From NeoGenomics, Inc.
Via Business Wire
News headline image
3 Russell 2000 Stocks We Think Twice About
Via StockStory
News headline image
3 Stocks Under $50 We Steer Clear Of
Via StockStory
News headline image
NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics to Present New ctDNA Research at SABCS 2025
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics to Present Real-World Study on Comprehensive Genomic Profiling in Myeloid Malignancies at ASH 2025
From NeoGenomics, Inc.
Via Business Wire
News headline image
Testing & Diagnostics Services Stocks Q3 Recap: Benchmarking NeoGenomics (NASDAQ:NEO)
Via StockStory
News headline image
3 Overrated Stocks That Concern Us
Via StockStory

Frequently Asked Questions

Is NeoGenomics, Inc. - Common Stock publicly traded?
Yes, NeoGenomics, Inc. - Common Stock is publicly traded.
What exchange does NeoGenomics, Inc. - Common Stock trade on?
NeoGenomics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for NeoGenomics, Inc. - Common Stock?
The ticker symbol for NeoGenomics, Inc. - Common Stock is NEO on the Nasdaq Stock Market
What is the current price of NeoGenomics, Inc. - Common Stock?
The current price of NeoGenomics, Inc. - Common Stock is 9.540
When was NeoGenomics, Inc. - Common Stock last traded?
The last trade of NeoGenomics, Inc. - Common Stock was at 03/03/26 04:00 PM ET
What is the market capitalization of NeoGenomics, Inc. - Common Stock?
The market capitalization of NeoGenomics, Inc. - Common Stock is 1.17B
How many shares of NeoGenomics, Inc. - Common Stock are outstanding?
NeoGenomics, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.